
Core Viewpoint - Helen of Troy (HELE) reported quarterly earnings of $2.33 per share, slightly missing the Zacks Consensus Estimate of $2.34 per share, and down from $2.45 per share a year ago, indicating a -0.43% earnings surprise [1] Financial Performance - The company posted revenues of $485.89 million for the quarter ended February 2025, surpassing the Zacks Consensus Estimate by 1.17%, but down from $489.2 million year-over-year [2] - Over the last four quarters, Helen of Troy has surpassed consensus EPS estimates two times and topped consensus revenue estimates three times [2] Stock Performance - Helen of Troy shares have declined approximately 43% since the beginning of the year, compared to a decline of -8.6% for the S&P 500 [3] - The stock is currently rated Zacks Rank 4 (Sell), indicating expectations of underperformance in the near future [6] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $1.22 on revenues of $437.74 million, and for the current fiscal year, it is $7.63 on revenues of $1.96 billion [7] - The estimate revisions trend for Helen of Troy has been unfavorable ahead of the earnings release [6] Industry Context - The Cosmetics industry, to which Helen of Troy belongs, is currently ranked in the bottom 7% of over 250 Zacks industries, suggesting potential challenges ahead [8] - European Wax Center, Inc. (EWCZ), another company in the same industry, is expected to report a significant year-over-year earnings decline of -61.5% in its upcoming report [9]